New York, NY, United States of America

Cindy M Hodakoski

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Beth Israel Deaconess Medical Center, Inc., Cornell University, Pfizer Corporation. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cindy M Hodakoski. Retrieved from https://idiyas.com/inventor/cindy-m-hodakoski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Cindy M Hodakoski

Introduction

Cindy M Hodakoski is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of targeted therapies. Her work has the potential to impact cancer treatment and improve patient outcomes.

Latest Patents

Cindy holds 1 patent related to CDCP1 antibodies and antibody drug conjugates. This patent provides materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy, showcasing her innovative approach to addressing complex medical challenges.

Career Highlights

Throughout her career, Cindy has worked with esteemed organizations such as Beth Israel Deaconess Medical Center and Pfizer Corporation. Her experience in these leading institutions has allowed her to contribute to groundbreaking research and development in the medical field.

Collaborations

Cindy has collaborated with notable professionals, including Lewis C Cantley and Stephen P Soltoff. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Cindy M Hodakoski's contributions to biotechnology and her innovative patent on CDCP1-targeted therapy highlight her role as a leading inventor in her field. Her work continues to inspire advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…